Second Course of Recombinant Human Activated Protein C Delivered to a Severely Septic Patient After Recent Surgery
- 1 May 2008
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Trauma: Injury, Infection & Critical Care
- Vol. 64 (5) , 1370-1372
- https://doi.org/10.1097/01.ta.0000195999.18928.dc
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The protein C pathwayCritical Care Medicine, 2000
- RECOMBINANT HUMAN ACTIVATED PROTEIN C (rhAPC) PRODUCES A TREND TOWARD IMPROVEMENT IN MORBIDITY AND 28 DAY SURVIVAL IN PATIENTS WITH SEVERE SEPSISCritical Care Medicine, 1999
- Has the mortality of septic shock changed with time?Critical Care Medicine, 1998
- The sirens' songs of confirmatory sepsis trialsCritical Care Medicine, 1998
- Epidemiology of Sepsis Syndrome in 8 Academic Medical CentersJAMA, 1997
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- The Protein C Pathway: New InsightsThrombosis and Haemostasis, 1997
- Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in AdultsJAMA, 1995
- An update on clinical and basic aspects of the protein C anticoagulant pathwayTrends in Cardiovascular Medicine, 1995
- Recombinant human protein C, protein S and thrombomodulin as antithromboticsPerspectives in Drug Discovery and Design, 1994